Conference Proceeding

ASYMS-SERAT: A Side-Effect Risk Assessment Tool to Predict Chemotherapy Related Toxicity in Patients with Cancer Receiving Chemotherapy

Details

Citation

Cowie J, Swingler K, Leadbetter C, Maguire R, McCall K & Kearney N (2008) ASYMS-SERAT: A Side-Effect Risk Assessment Tool to Predict Chemotherapy Related Toxicity in Patients with Cancer Receiving Chemotherapy. In: Azevedo L & Londral AR (eds.) Proceedings of the First International Conference on Health Informatics, HEALTHINF 2008, Funchal, Madeira, Portugal, January 28-31, 2008, Volume 2. HEALTHINF - International Conference on Health Informatics 2008, Madeira, Portugal, 28.01.2008-31.01.2008. Setubal, Portugal: INSTICC - Institute for Systems and Technologies of Information, Control and Communication, pp. 225-230. http://www.healthinf.biostec.org/Healthinf2008/

Abstract
Patients undergoing chemotherapy want specific information on potential toxicities of their treatment. Such information includes what side-effects they are likely to experience, how severe these side-effects will be, how long they will experience them for, and the best ways of managing them. As well as improving the experiences of patients, information about potential side-effects may also be of significant benefit clinically, as patients who are ‘at risk’ of developing certain toxicities may be identified, facilitating more targeted, cost-effective interventions. This paper describes research which uses risk modelling techniques for identifying patterns in patient side-effect data to aid in predicting side-effects patients are likely to experience. Through analysis of patient data, a patient can receive information specific to the symptoms they are likely to experience. A user-friendly software tool SERAT (Side-Effect Risk Assessment Tool) has been developed, which presents side-effect information to the patients both at the start of treatment and reviews and monitors predictions with each new cycle of chemotherapy received.

Keywords
Risk modelling; side-effect prediction; cancer; chemotherapy; Cancer Chemotherapy; Cancer Research; Health risk assessment

StatusPublished
Publication date31/12/2008
URLhttp://hdl.handle.net/1893/1976
Related URLshttp://www.healthinf.biostec.org/HEALTHINF2008/
PublisherINSTICC - Institute for Systems and Technologies of Information, Control and Communication
Publisher URLhttp://www.healthinf.biostec.org/Healthinf2008/
Place of publicationSetubal, Portugal
ISBN978-989-8111-16-6
ConferenceHEALTHINF - International Conference on Health Informatics 2008
Conference locationMadeira, Portugal
Dates

People (2)

People

Dr Julie Cowie
Dr Julie Cowie

Senior Research Fellow, NMAHP

Dr Kevin Swingler
Dr Kevin Swingler

Head of Division of CSM, Computing Science